RE: Parsortix vs the rest9 Jan 2025 07:35
Cont...
Conversation with Gemini
why is Parsortix is superior vs plain old FACS and/or EpCAM antibodies/chips and in general any of the other platforms out there?
2.0 Flash Experimental. Might not work as expected.
Parsortix offers several advantages over traditional methods like FACS and EpCAM-based approaches for isolating circulating tumor cells (CTCs):
Unbiased Capture: Unlike EpCAM-based methods that rely on a single surface marker, Parsortix captures CTCs based on their physical properties (size and compressibility). This is crucial because CTCs can be heterogeneous and may lose EpCAM expression during metastasis, leading to their escape from capture by EpCAM-based methods.
Intact and Viable Cells: Parsortix isolates CTCs gently, preserving their integrity and viability. This is essential for downstream analyses like single-cell sequencing, gene expression profiling, and functional studies, which require intact and viable cells.
No Antibody Interference: Since Parsortix doesn't use antibodies for capture, it avoids potential issues like antibody-induced cell activation or masking of epitopes, which can interfere with downstream analyses.
High Purity: Parsortix provides high purity CTCs with minimal contamination from other blood cells, improving the sensitivity and accuracy of downstream analyses.
Automation and Standardization: Parsortix is a semi-automated system that can process multiple samples in parallel, providing standardized and reproducible results.
These advantages make Parsortix a superior platform for CTC isolation compared to traditional methods, enabling more comprehensive and accurate CTC analysis for research and clinical applications.
Sign In
Follow the stocks
